APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transforming Growth Factor Beta 1

Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene

Selected research

Market Structure

Global Transforming Growth Factor Beta 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025190 pages

Choose your research edition.

Industry ResearchTransforming Growth Factor Beta 1 Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Transforming Growth Factor Beta 1 Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Transforming Growth Factor Beta 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transforming Growth Factor Beta 1 Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Transforming Growth Factor Beta 1 Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene

North America is the largest Transforming Growth Factor Beta 1 market with about 69% market share. Europe is follower, accounting for about 16% market share.The key manufacturers are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG etc.

This report provides an overview of the global Transforming Growth Factor Beta 1 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Transforming Growth Factor Beta 1 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Transforming Growth Factor Beta 1 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Transforming Growth Factor Beta 1 market size, projected growth trends, production technologies, key applications, and end-use industries.

Transforming Growth Factor Beta 1 Segment by Company

Roche

Shionogi Ltd

Acceleron Pharma Inc

Genzyme Corp

Isarna Therapeutics GmbH

Scholar Rock

Sirnaomics Inc

Eli Lilly and Co

Formation Biologics Inc

Novartis AG

Transforming Growth Factor Beta 1 Segment by Type

Pirfenidone

Galunisertib

Others

Transforming Growth Factor Beta 1 Segment by Application

IPF

Cancer

Others

Transforming Growth Factor Beta 1 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transforming Growth Factor Beta 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transforming Growth Factor Beta 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transforming Growth Factor Beta 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Transforming Growth Factor Beta 1 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Transforming Growth Factor Beta 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Transforming Growth Factor Beta 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Transforming Growth Factor Beta 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Transforming Growth Factor Beta 1 Industry Trends Table 2. Transforming Growth Factor Beta 1 Industry Drivers Table 3. Transforming Growth Factor Beta 1 Industry Opportunities and Challenges Table 4. Transforming Growth Factor Beta 1 Industry Restraints Table 5. Global Transforming Growth Factor Beta 1 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Transforming Growth Factor Beta 1 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Transforming Growth Factor Beta 1 Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Transforming Growth Factor Beta 1 Sales Market Share by Manufacturers Table 9. Global Transforming Growth Factor Beta 1 Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Transforming Growth Factor Beta 1 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Transforming Growth Factor Beta 1 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Transforming Growth Factor Beta 1 Manufacturers, Product Type & Application Table 13. Global Transforming Growth Factor Beta 1 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Transforming Growth Factor Beta 1 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Pirfenidone Table 17. Major Manufacturers of Galunisertib Table 18. Major Manufacturers of Others Table 19. Global Transforming Growth Factor Beta 1 Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Transforming Growth Factor Beta 1 Sales by Type (2021-2026) & (K Units) Table 21. Global Transforming Growth Factor Beta 1 Sales by Type (2027-2032) & (K Units) Table 22. Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2021-2026) Table 23. Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2027-2032) Table 24. Global Transforming Growth Factor Beta 1 Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Transforming Growth Factor Beta 1 Revenue by Type (2021-2026) & (K Units) Table 26. Global Transforming Growth Factor Beta 1 Revenue by Type (2027-2032) & (K Units) Table 27. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2021-2026) Table 28. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of IPF Table 30. Major Manufacturers of Cancer Table 31. Major Manufacturers of Others Table 32. Global Transforming Growth Factor Beta 1 Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Transforming Growth Factor Beta 1 Sales by Application (2021-2026) & (K Units) Table 34. Global Transforming Growth Factor Beta 1 Sales by Application (2027-2032) & (K Units) Table 35. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2021-2026) Table 36. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2027-2032) Table 37. Global Transforming Growth Factor Beta 1 Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Transforming Growth Factor Beta 1 Revenue by Application (2021-2026) & (K Units) Table 39. Global Transforming Growth Factor Beta 1 Revenue by Application (2027-2032) & (K Units) Table 40. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2021-2026) Table 41. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2027-2032) Table 42. Global Transforming Growth Factor Beta 1 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Transforming Growth Factor Beta 1 Sales by Region (2021-2026) & (K Units) Table 44. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2021-2026) Table 45. Global Transforming Growth Factor Beta 1 Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Transforming Growth Factor Beta 1 Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Transforming Growth Factor Beta 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Transforming Growth Factor Beta 1 Sales by Country (2021-2026) & (K Units) Table 49. North America Transforming Growth Factor Beta 1 Sales by Country (2027-2032) & (K Units) Table 50. Europe Transforming Growth Factor Beta 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Transforming Growth Factor Beta 1 Sales by Country (2021-2026) & (K Units) Table 52. Europe Transforming Growth Factor Beta 1 Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Transforming Growth Factor Beta 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Transforming Growth Factor Beta 1 Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Transforming Growth Factor Beta 1 Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Transforming Growth Factor Beta 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2027-2032) & (K Units) Table 59. Global Transforming Growth Factor Beta 1 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Transforming Growth Factor Beta 1 Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Transforming Growth Factor Beta 1 Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2021-2026) Table 63. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2027-2032) Table 64. Roche Company Information Table 65. Roche Business Overview Table 66. Roche Transforming Growth Factor Beta 1 Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Roche Transforming Growth Factor Beta 1 Product Portfolio Table 68. Roche Recent Development Table 69. Shionogi Ltd Company Information Table 70. Shionogi Ltd Business Overview Table 71. Shionogi Ltd Transforming Growth Factor Beta 1 Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Shionogi Ltd Transforming Growth Factor Beta 1 Product Portfolio Table 73. Shionogi Ltd Recent Development Table 74. Acceleron Pharma Inc Company Information Table 75. Acceleron Pharma Inc Business Overview Table 76. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Portfolio Table 78. Acceleron Pharma Inc Recent Development Table 79. Genzyme Corp Company Information Table 80. Genzyme Corp Business Overview Table 81. Genzyme Corp Transforming Growth Factor Beta 1 Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Genzyme Corp Transforming Growth Factor Beta 1 Product Portfolio Table 83. Genzyme Corp Recent Development Table 84. Isarna Therapeutics GmbH Company Information Table 85. Isarna Therapeutics GmbH Business Overview Table 86. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Portfolio Table 88. Isarna Therapeutics GmbH Recent Development Table 89. Scholar Rock Company Information Table 90. Scholar Rock Business Overview Table 91. Scholar Rock Transforming Growth Factor Beta 1 Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Scholar Rock Transforming Growth Factor Beta 1 Product Portfolio Table 93. Scholar Rock Recent Development Table 94. Sirnaomics Inc Company Information Table 95. Sirnaomics Inc Business Overview Table 96. Sirnaomics Inc Transforming Growth Factor Beta 1 Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Sirnaomics Inc Transforming Growth Factor Beta 1 Product Portfolio Table 98. Sirnaomics Inc Recent Development Table 99. Eli Lilly and Co Company Information Table 100. Eli Lilly and Co Business Overview Table 101. Eli Lilly and Co Transforming Growth Factor Beta 1 Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Eli Lilly and Co Transforming Growth Factor Beta 1 Product Portfolio Table 103. Eli Lilly and Co Recent Development Table 104. Formation Biologics Inc Company Information Table 105. Formation Biologics Inc Business Overview Table 106. Formation Biologics Inc Transforming Growth Factor Beta 1 Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Formation Biologics Inc Transforming Growth Factor Beta 1 Product Portfolio Table 108. Formation Biologics Inc Recent Development Table 109. Novartis AG Company Information Table 110. Novartis AG Business Overview Table 111. Novartis AG Transforming Growth Factor Beta 1 Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Novartis AG Transforming Growth Factor Beta 1 Product Portfolio Table 113. Novartis AG Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Transforming Growth Factor Beta 1 Distributors List Table 117. Transforming Growth Factor Beta 1 Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Transforming Growth Factor Beta 1 Product Image Figure 2. Global Transforming Growth Factor Beta 1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transforming Growth Factor Beta 1 Market Size (2021-2032) & (US$ Million) Figure 4. Global Transforming Growth Factor Beta 1 Sales (2021-2032) & (K Units) Figure 5. Global Transforming Growth Factor Beta 1 Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Transforming Growth Factor Beta 1 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Pirfenidone Image Figure 9. Galunisertib Image Figure 10. Others Image Figure 11. Global Transforming Growth Factor Beta 1 Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Transforming Growth Factor Beta 1 Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2021-2032) Figure 14. Global Transforming Growth Factor Beta 1 Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Transforming Growth Factor Beta 1 Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2021-2032) Figure 17. IPF Image Figure 18. Cancer Image Figure 19. Others Image Figure 20. Global Transforming Growth Factor Beta 1 Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Transforming Growth Factor Beta 1 Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2021-2032) Figure 23. Global Transforming Growth Factor Beta 1 Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Transforming Growth Factor Beta 1 Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2021-2032) Figure 26. North America Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Transforming Growth Factor Beta 1 Sales Market Share by Country (2021-2032) Figure 28. U.S. Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Transforming Growth Factor Beta 1 Sales Market Share by Country (2021-2032) Figure 33. Germany Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Transforming Growth Factor Beta 1 Sales Market Share by Country (2021-2032) Figure 40. China Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share by Country (2021-2032) Figure 48. Brazil Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Transforming Growth Factor Beta 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Transforming Growth Factor Beta 1 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Figure 59. North America Transforming Growth Factor Beta 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Figure 61. Europe Transforming Growth Factor Beta 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Transforming Growth Factor Beta 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Transforming Growth Factor Beta 1 Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Transforming Growth Factor Beta 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Transforming Growth Factor Beta 1 Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Transforming Growth Factor Beta 1 Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Pirfenidone
  • Galunisertib
  • Others
Applications
  • IPF
  • Cancer
  • Others
Companies covered
  • Roche
  • Shionogi Ltd
  • Acceleron Pharma Inc
  • Genzyme Corp
  • Isarna Therapeutics GmbH
  • Scholar Rock
  • Sirnaomics Inc
  • Eli Lilly and Co
  • Formation Biologics Inc
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Transforming Growth Factor Beta 1 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Transforming Growth Factor Beta 1 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Transforming Growth Factor Beta 1 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Transforming Growth Factor Beta 1 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Transforming Growth Factor Beta 1 Market Dynamics
  1. 2.1 Transforming Growth Factor Beta 1 Industry Trends
  2. 2.2 Transforming Growth Factor Beta 1 Industry Drivers
  3. 2.3 Transforming Growth Factor Beta 1 Industry Opportunities and Challenges
  4. 2.4 Transforming Growth Factor Beta 1 Industry Restraints
3 Transforming Growth Factor Beta 1 Market by Manufacturers
  1. 3.1 Global Transforming Growth Factor Beta 1 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Transforming Growth Factor Beta 1 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Transforming Growth Factor Beta 1 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Transforming Growth Factor Beta 1 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Transforming Growth Factor Beta 1 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Transforming Growth Factor Beta 1 Manufacturers, Product Type & Application
  7. 3.7 Global Transforming Growth Factor Beta 1 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Transforming Growth Factor Beta 1 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Transforming Growth Factor Beta 1 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Transforming Growth Factor Beta 1 Tier 1, Tier 2, and Tier 3
4 Transforming Growth Factor Beta 1 Market by Type
  1. 4.1 Transforming Growth Factor Beta 1 Type Introduction
  2. 4.1.1 Pirfenidone
  3. 4.1.2 Galunisertib
  4. 4.1.3 Others
  5. 4.2 Global Transforming Growth Factor Beta 1 Sales by Type
  6. 4.2.1 Global Transforming Growth Factor Beta 1 Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Transforming Growth Factor Beta 1 Sales by Type (2021-2032)
  8. 4.2.3 Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2021-2032)
  9. 4.3 Global Transforming Growth Factor Beta 1 Revenue by Type
  10. 4.3.1 Global Transforming Growth Factor Beta 1 Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Transforming Growth Factor Beta 1 Revenue by Type (2021-2032)
  12. 4.3.3 Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2021-2032)
5 Transforming Growth Factor Beta 1 Market by Application
  1. 5.1 Transforming Growth Factor Beta 1 Application Introduction
  2. 5.1.1 IPF
  3. 5.1.2 Cancer
  4. 5.1.3 Others
  5. 5.2 Global Transforming Growth Factor Beta 1 Sales by Application
  6. 5.2.1 Global Transforming Growth Factor Beta 1 Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Transforming Growth Factor Beta 1 Sales by Application (2021-2032)
  8. 5.2.3 Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2021-2032)
  9. 5.3 Global Transforming Growth Factor Beta 1 Revenue by Application
  10. 5.3.1 Global Transforming Growth Factor Beta 1 Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Transforming Growth Factor Beta 1 Revenue by Application (2021-2032)
  12. 5.3.3 Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2021-2032)
6 Global Transforming Growth Factor Beta 1 Sales by Region
  1. 6.1 Global Transforming Growth Factor Beta 1 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Transforming Growth Factor Beta 1 Sales by Region (2021-2032)
  3. 6.2.1 Global Transforming Growth Factor Beta 1 Sales by Region (2021-2026)
  4. 6.2.2 Global Transforming Growth Factor Beta 1 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Transforming Growth Factor Beta 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Transforming Growth Factor Beta 1 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Transforming Growth Factor Beta 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Transforming Growth Factor Beta 1 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Transforming Growth Factor Beta 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Transforming Growth Factor Beta 1 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Transforming Growth Factor Beta 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Transforming Growth Factor Beta 1 Revenue by Region
  1. 7.1 Global Transforming Growth Factor Beta 1 Revenue by Region
  2. 7.1.1 Global Transforming Growth Factor Beta 1 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Transforming Growth Factor Beta 1 Revenue by Region (2021-2026)
  4. 7.1.3 Global Transforming Growth Factor Beta 1 Revenue by Region (2027-2032)
  5. 7.1.4 Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Transforming Growth Factor Beta 1 Revenue (2021-2032)
  8. 7.2.2 North America Transforming Growth Factor Beta 1 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Transforming Growth Factor Beta 1 Revenue (2021-2032)
  11. 7.3.2 Europe Transforming Growth Factor Beta 1 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Transforming Growth Factor Beta 1 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Transforming Growth Factor Beta 1 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Transforming Growth Factor Beta 1 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Transforming Growth Factor Beta 1 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Roche Transforming Growth Factor Beta 1 Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Shionogi Ltd
  8. 8.2.1 Shionogi Ltd Company Information
  9. 8.2.2 Shionogi Ltd Business Overview
  10. 8.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shionogi Ltd Transforming Growth Factor Beta 1 Product Portfolio
  12. 8.2.5 Shionogi Ltd Recent Developments
  13. 8.3 Acceleron Pharma Inc
  14. 8.3.1 Acceleron Pharma Inc Company Information
  15. 8.3.2 Acceleron Pharma Inc Business Overview
  16. 8.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Portfolio
  18. 8.3.5 Acceleron Pharma Inc Recent Developments
  19. 8.4 Genzyme Corp
  20. 8.4.1 Genzyme Corp Company Information
  21. 8.4.2 Genzyme Corp Business Overview
  22. 8.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Genzyme Corp Transforming Growth Factor Beta 1 Product Portfolio
  24. 8.4.5 Genzyme Corp Recent Developments
  25. 8.5 Isarna Therapeutics GmbH
  26. 8.5.1 Isarna Therapeutics GmbH Company Information
  27. 8.5.2 Isarna Therapeutics GmbH Business Overview
  28. 8.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Portfolio
  30. 8.5.5 Isarna Therapeutics GmbH Recent Developments
  31. 8.6 Scholar Rock
  32. 8.6.1 Scholar Rock Company Information
  33. 8.6.2 Scholar Rock Business Overview
  34. 8.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Scholar Rock Transforming Growth Factor Beta 1 Product Portfolio
  36. 8.6.5 Scholar Rock Recent Developments
  37. 8.7 Sirnaomics Inc
  38. 8.7.1 Sirnaomics Inc Company Information
  39. 8.7.2 Sirnaomics Inc Business Overview
  40. 8.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sirnaomics Inc Transforming Growth Factor Beta 1 Product Portfolio
  42. 8.7.5 Sirnaomics Inc Recent Developments
  43. 8.8 Eli Lilly and Co
  44. 8.8.1 Eli Lilly and Co Company Information
  45. 8.8.2 Eli Lilly and Co Business Overview
  46. 8.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Eli Lilly and Co Transforming Growth Factor Beta 1 Product Portfolio
  48. 8.8.5 Eli Lilly and Co Recent Developments
  49. 8.9 Formation Biologics Inc
  50. 8.9.1 Formation Biologics Inc Company Information
  51. 8.9.2 Formation Biologics Inc Business Overview
  52. 8.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Formation Biologics Inc Transforming Growth Factor Beta 1 Product Portfolio
  54. 8.9.5 Formation Biologics Inc Recent Developments
  55. 8.10 Novartis AG
  56. 8.10.1 Novartis AG Company Information
  57. 8.10.2 Novartis AG Business Overview
  58. 8.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Novartis AG Transforming Growth Factor Beta 1 Product Portfolio
  60. 8.10.5 Novartis AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Transforming Growth Factor Beta 1 Value Chain Analysis
  2. 9.1.1 Transforming Growth Factor Beta 1 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Transforming Growth Factor Beta 1 Production Mode & Process
  6. 9.2 Transforming Growth Factor Beta 1 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Transforming Growth Factor Beta 1 Distributors
  9. 9.2.3 Transforming Growth Factor Beta 1 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst